Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis [Phase 3]
This update reports the completion of a Phase 3 study evaluating fampridine-ER tablets in patients with multiple sclerosis, with results pos…
-
CLINICAL_TRIALS research · 2013-08-08Clinical Trial Update: Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients [NA]
This clinical trial update evaluates the effect of I-TRAVLE Training on arm function in people with multiple sclerosis and chronic stroke.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Comprehensive Analysis of Relapse in Multiple Sclerosis [NA]
A clinical trial record provides a comprehensive analysis of relapse in multiple sclerosis; the trial status and phase are not specified.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Exercise in Severely Disabled Patients With MS [Phase 1]
This is a Phase 1 clinical trial update describing an exercise program for severely disabled patients with multiple sclerosis. The study sta…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS [Phase 3]
Phase 3 trial assessing safety and efficacy of AVP-923 for pseudobulbar affect in patients with ALS or MS; results were posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) [Phase 2]
Phase 2 trial evaluating cladribine added to interferon-beta in active multiple sclerosis; study completed with results posted in 2013.
-
FDA approval · 2013-06-28FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for BETASERON (interferon beta-1b) by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Safety of Polyphenon E in Multiple Sclerosis Pilot Study [Phase 1]
Phase 1 safety pilot of Polyphenon E in individuals with Multiple Sclerosis has been completed and results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis [Phase 3]
Phase 3 efficacy study results for teriflunomide in relapsing multiple sclerosis have been posted.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis
A completed clinical trial evaluating factors associated with early discontinuation of Betaferon injections in people with multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy [NA]
This completed clinical trial evaluated weekly longitudinal imaging of active multiple sclerosis plaques using 3 Tesla multi-modality MRI to…
-
EMA guidance · 2013-06-20Registration open for workshop on the clinical investigation of medicines for the treatment of multiple sclerosis
EMA announces registration is open for a workshop focused on the clinical investigation of medicines for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of combining Cellcept (mycophenolate mofetil) with Avonex (interferon beta-1a) for multip…
-
FDA approval · 2013-06-18FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
FDA approved a supplemental application for AMPYRA (dalfampridine) from Merz Pharmaceuticals, LLC. The action authorizes changes to the prod…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
This trial update analyzes lymphocyte cell surface adhesion marker expression in Natalizumab-treated MS patients using an active-control com…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
A completed pilot study evaluating functional and physiological responses to Lokomat robotic gait therapy in spinal cord injury, multiple sc…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Improving New Learning and Memory in Multiple Sclerosis [NA]
This update notes the completed clinical trial sponsored by the Kessler Foundation investigating improving new learning and memory in people…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: The Effect of Anodal tDCS on Motor Learning in Multiple Sclerosis [NA]
A completed clinical trial evaluated the effect of anodal transcranial direct current stimulation on motor learning in individuals with mult…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)
A retrospective cohort study assessing Rebif (interferon beta-1a) use in pediatric multiple sclerosis provides observational data on safety …
-
FDA approval · 2013-05-28FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Avonex®: Safety, Blood Levels and Effects [Phase 1]
Phase 1 study of Avonex (interferon beta-1a) in multiple sclerosis reports safety, pharmacokinetics (blood levels), and observed effects.
-
FDA approval · 2013-05-24FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved a Biogen supplemental application for TYSABRI (Natalizumab). The action indicates a modification/expansion of the product l…
-
CLINICAL_TRIALS research · 2013-05-17Clinical Trial Update: Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner
This clinical trial update describes a University of Nottingham study using ultra-high-field 7T MRI to investigate gray matter pathology in …
-
CLINICAL_TRIALS research · 2013-05-16Clinical Trial Update: MEsenchymal StEm Cells for Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update for mesenchymal stem cells as a potential therapy for multiple sclerosis in Phase 1/Phase 2, sponsored by Antonio Ucce…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Occupational Therapy in Patients With Multiple Sclerosis [NA]
This clinical trial update indicates that the occupational therapy study in patients with multiple sclerosis and apraxia has completed.